Litigation Details for UCB Inc. v. Zydus Worldwide DMCC (D. Del. 2016)
✉ Email this page to a colleague
UCB Inc. v. Zydus Worldwide DMCC (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-11-03 |
| Court | District Court, D. Delaware | Date Terminated | 2020-10-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | UCB INC. | ||
| Patents | 6,699,498; 6,884,434; 7,413,747; 8,246,979; 8,246,980; 8,617,591; 9,925,150 | ||
| Attorneys | Megan C. Haney | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB Inc. v. Zydus Worldwide DMCC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for UCB Inc. v. Zydus Worldwide DMCC (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-11-03 | 1 | (“the ’591 Patent”); and 6,884,434 (“the ’434 Patent”). Plaintiffs Case 1:16-cv-01023-LPS Document 1…infringement of the ’979 Patent; the ’980 Patent; the ’591 Patent; and the ’434 Patent. This Court has jurisdiction… United States Patent Nos. 8,246,979 (“the ’979 Patent”); 8,246,980 (“the ’980 Patent”); 8,617,591 (“… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…. This civil action for patent infringement arises under the patent laws of the United States, including | External link to document | |
| 2018-05-25 | 133 | Notice of Service | Initial Infringement Contentions for U.S. Patent No. 9,925,150 B2 filed by LTS Lohmann Therapie-Systeme…2016 7 October 2020 1:16-cv-01023 830 Patent None District Court, D. Delaware | External link to document |
| 2018-06-01 | 137 | Opinion - Memorandum Opinion | Zydus"), alleging infringement of U.S. Patent Nos. 6,884,434, 8,617,591, and 8,246,979. Presently…one term appearing in the '434 patent. The '434 patent describes and claims transdermal therapeutic…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification …13 of the ' 979 patent and claims 1, 2, 3, 10, and 11 of the '59 1 patent, as "particulate | External link to document |
| 2018-06-27 | 145 | Patent/Trademark Report to Commissioner of Patents | ,246,980 ;8,617,591 ;6,699,498 ;7,413,747 . (Phillips, John) (Entered: 06/27/2018) 27 June 2018 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,246,979 ;8,246,980…2016 7 October 2020 1:16-cv-01023 830 Patent None District Court, D. Delaware | External link to document |
| 2018-06-27 | 147 | Notice of Service | Initial Invalidity Contentions for U.S. Patent No. 9,925,150 filed by Zydus Pharmaceuticals USA, Inc.…2016 7 October 2020 1:16-cv-01023 830 Patent None District Court, D. Delaware | External link to document |
| 2018-07-10 | 150 | Notice of Service | of Claim Terms for Construction from U.S. Patent No. 9,925,150 filed by Zydus Pharmaceuticals USA, Inc.…2016 7 October 2020 1:16-cv-01023 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
